Stockreport

Analysts Adjust Cadrenal Therapeutics, Inc. (CVKD) Valuation After Including CAD-1005 Program [Yahoo! Finance]

Cadrenal Therapeutics, Inc.  (CVKD) 
PDF TheFly reported on April 7 that H.C. Wainwright reduced its price target on CVKD from $32 to $13 while maintaining a Buy rating. The adjustment reflects updated assumpt [Read more]